Aimei Health Technology Co Unit
AFJKU
2 hedge funds and large institutions have $25.6K invested in Aimei Health Technology Co Unit in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
0% more capital invested
Capital invested by funds: $25.6K → $25.6K (+$78)
0% more ownership
Funds ownership: 0.04% → 0.04% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$78 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
1
Clear Street
New York
| $25.6K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $78 | +$78 | +7 | New |
|
AFJKU Hedge Fund Activity: Q3 2025 in Review
2 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in Aimei Health Technology Co Unit (AFJKU) for Q3 2025, worth a combined $25.6K — up 0.31% from $25.6K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new AFJKU positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $78.
- 2 institutional investors held Aimei Health Technology Co Unit (AFJKU) as of Q3 2025, up from 1 in Q2 2025.
- Funds reported $25.6K of Aimei Health Technology Co Unit stock for Q3 2025, up 0.31% quarter-over-quarter.
- 1 fund opened new Aimei Health Technology Co Unit positions in Q3 2025 and 0 closed out, a net change of +1 holder.
- The largest Aimei Health Technology Co Unit buyer in Q3 2025 was UBS Group, an estimated $78 added.
Based on aggregated 13F filings for Q3 2025.